CHEN Hao 1,2,3 , ZHU Jianwei 1,2,3 , SHI Hongcan 1,2,3
  • 1. Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225009, Jiangsu, P. R. China;
  • 2. Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225009, Jiangsu, P. R. China;
  • 3. Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225009, Jiangsu, P. R. China;
SHI Hongcan, Email: shihongcan@yzu.edu.cn
Export PDF Favorites Scan Get Citation

The extracellular matrix provides a unique tissue-specific microenvironment for resident cells, supporting the essential functions required for tissue architecture and biochemical signaling. Decellularized extracellular matrix (dECM) is designed to eliminate cells that mediate immunological rejection while preserving the native tissue structure and matrix functionality. dECM has attracted significant attention in tissue engineering applications and has evolved into a novel and increasingly sophisticated biomaterial. This article summarizes representative protocols for decellularization methods, explores the latest applications of decellularized tissue-derived materials and bioinks in the field of cardiothoracic surgery, analyzes the current challenges and issues confronting dECM, and discusses future perspectives for its development.

Citation: CHEN Hao, ZHU Jianwei, SHI Hongcan. Research progress of decellularized extracellular matrix in the field of tissue engineering in thoracic and cardiac surgery. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2025, 32(6): 863-868. doi: 10.7507/1007-4848.202403068 Copy

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress on the pathogenesis of chronic obstructive pulmonary disease complicated with lung cancer
  • Next Article

    Research progress on unplanned readmissions in patients with left ventricular assist devices